The impact of the COVID-19 pandemic on paediatric emergency service

İlknur Fidancı1, Medine Ayşin Taşar1, Bahar Akıntuğ2

  • 1Department of Pediatric Emergency, Ankara Training and Research Hospital, University of Health Sciences, Ankara, Turkey.

Insights

The COVID-19 pandemic saw a 67.7% decrease in pediatric emergency visits, with a concerning threefold increase in child mortality rates. Public awareness is crucial to ensure children receive timely emergency care despite infection control measures.

Area of Science:

  • Pediatric Emergency Medicine
  • Epidemiology
  • Public Health

Background:

  • The COVID-19 pandemic significantly impacted healthcare utilization globally.
  • Paediatric emergency departments (PEDs) experienced changes in patient volumes and case demographics.
  • Understanding these shifts is vital for assessing secondary health impacts on children.

Purpose of the Study:

  • To analyze patient visits to a paediatric emergency department before and during the COVID-19 pandemic.
  • To review paediatric emergency department referral ratios.
  • To determine changes in paediatric mortality and morbidity during the pandemic.

Main Methods:

  • Retrospective cross-sectional study of patients aged 0-18 years.
  • Data collected from Ankara Research and Training Hospital's paediatric emergency service.
  • Comparison of data from April-October 2019 (pre-pandemic) and April-October 2020 (during pandemic).

Main Results:

  • A 67.7% decrease in total paediatric emergency consultations was observed during the pandemic.
  • COVID-19-related symptoms increased, with fever and gastroenteritis as common diagnoses.
  • A threefold increase in mortality rates and a decrease in suicide attempt consultations were noted during the pandemic.

Conclusions:

  • The significant reduction in paediatric emergency visits may lead to adverse secondary health outcomes for children.
  • Increased awareness is needed regarding the importance of seeking emergency care for children.
  • Hospitals must maintain stringent health precautions to ensure safe access to care during health crises.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
58
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
71
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
49
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68